Cited 0 times in
Isatuximab in Combination with Lenalidomide and Dexamethasone in Patients with High-Risk Smoldering Multiple Myeloma: Updated Safety Run-in Results from the Randomized Phase 3 Ithaca Study
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.